Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary Goldenberg, MD
Mount Sinai School of Medicine, Dermatology Faculty
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kirk Barber Research
Calgary, Alberta, Canada
- Enverus Medical
Surrey, British Columbia, Canada
- Skin Care Centre
Vancouver, British Columbia, Canada
- Winnipeg Clinic Dermatology Research
Winnipeg, Manitoba, Canada
- Ultranova Skincare
Barrie, Ontario, Canada
- Dermatrials Research Incorporated
Hamilton, Ontario, Canada
- the Guenther Dermatology Research Centre
London, Ontario, Canada
- Skin Centre for Dermatology
Peterborough, Ontario, Canada
- Omni Dermatology
Phoenix, Arizona, United States
- Torrance Clinical Research Institute Inc.
Lomita, California, United States
- Dermatology Cosmetic Laser Medical Associates of la Jolla, Inc.
San Diego, California, United States
- Dermatology Associates and Research
Coral Gables, Florida, United States
- Leavitt Medical Associates of Florida
Ormond Beach, Florida, United States
- Deaconess Clinic, Inc.
Evansville, Indiana, United States
- Hudson Dermatology, Llc
Evansville, Indiana, United States
- Indiana Clinical Trials Center
Plainfield, Indiana, United States
- Dermassociates, Pc
Rockville, Maryland, United States
- Great Lakes Research Group, Inc.
Bay City, Michigan, United States
- the Dermatology Group, P.C.
Verona, New Jersey, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Pflugerville Dermatology Clinical Research Center, Inc.
Pflugerville, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2014
- Primary completion
- 31 May 2015
- Completion
- 31 May 2015
- Last update posted
- 6 Mar 2025
- Registered enrollment
- 224
- Registry id
- NCT02120456
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.